Aastrom regulatory update

The University of Michigan received two U.S. patents that are exclusively licensed to AASTROM. Patent No. 5,437,994 covers methods for the ex vivo replication of stem cells. The technology allows human stem cells to replicate in cell culture.

U.S. Patent No. 5,399,493 covers methods and compositions to optimize human hematopoietic progenitor cell cultures. The technology allows for the stable genetic modification of human stem cells. ...